FormWeb • panitumumab

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Add Formweb to your mobile device

Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

panitumumab

panitumumab

Restricted Anti-Neoplastic Formulary

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Vectibix	SOLUTION, INTRAVENOUS	20 mg/mL

VIEW MORE Antineoplastic Agents
CLASS

Comments:

Vectibix is restricted to oncology outpatient infusion centers.

Reviewed: November 14, 2006, and 24 Oct 2017 (Vectibix)

Last updated: May. 31, 2023

Black Box Warning: Dermatologic toxicity; infusion reactions
Formulary, Not Routinely Stocked: Vectibix --> 20 mg/mL solution

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.